ASMANEX

This brand name is authorized in United States. It is also authorized in Austria, Canada, Finland, France, Germany, Hong Kong SAR China, Ireland, Japan, New Zealand, Poland, Romania, Singapore, South Africa, Spain, UK.

Active ingredients

The drug ASMANEX contains one active pharmaceutical ingredient (API):

1	Mometasone UNII 04201GDN4R - MOMETASONE FUROATE
	Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade.
	Read more about Mometasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ASMANEX TWISTHALER Inhalation powder	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03BA07	Mometasone	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02243595, 02243596, 02438690
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02735450, 02735510
ES	Centro de información online de medicamentos de la AEMPS	65226, 65236
FI	Lääkealan turvallisuus- ja kehittämiskeskus	007516, 007549
FR	Base de données publique des médicaments	60268519, 69337532
GB	Medicines & Healthcare Products Regulatory Agency	40439, 40444, 40459, 40461
HK	Department of Health Drug Office	51293, 51294
JP	医薬品医療機器総合機構	2290703G1020, 2290703G2026
NZ	Medicines and Medical Devices Safety Authority	8952, 8953
PL	Rejestru Produktów Leczniczych	100130892, 100195437
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68206001, W68206002, W68207001, W68207002, W68207003
SG	Health Sciences Authority	11277P, 11278P, 13630P
US	FDA, National Drug Code	0085-1341, 0085-1461, 0085-2222, 0085-4333, 0085-4334
ZA	Health Products Regulatory Authority	34/21.5.1/0343, 34/21.5.1/0344